(CRRX) CareRx - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA14173C1059
CRRX: Medication, Management, Technology, Pharmacy, Solutions
CareRx Corporation, together with its subsidiaries, provides pharmacy services to seniors homes and other congregate care settings in Canada. The company offers medication management, technology, and program solutions. It serves long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is based in Toronto, Canada., Web URL: https://www.carerx.ca
Additional Sources for CRRX Stock
CRRX Stock Overview
| Market Cap in USD | 121m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Facilities |
| IPO / Inception |
CRRX Stock Ratings
| Growth 5y | -28.5% |
| Fundamental | 40.4% |
| Dividend | 0.0% |
| Rel. Strength Industry | 73.3 |
| Analysts | - |
| Fair Price Momentum | 2.81 CAD |
| Fair Price DCF | 9.37 CAD |
CRRX Dividends
No Dividends PaidCRRX Growth Ratios
| Growth Correlation 3m | 98.6% |
| Growth Correlation 12m | 9.5% |
| Growth Correlation 5y | -76.1% |
| CAGR 5y | -3.13% |
| CAGR/Max DD 5y | -0.04 |
| Sharpe Ratio 12m | 1.62 |
| Alpha | 93.35 |
| Beta | -0.69 |
| Volatility | 43.37% |
| Current Volume | 30.7k |
| Average Volume 20d | 59.6k |
What is the price of CRRX stocks?
As of February 22, 2025, the stock is trading at CAD 2.73 with a total of 30,673 shares traded.
Over the past week, the price has changed by +3.02%, over one month by +26.98%, over three months by +53.37% and over the past year by +77.27%.
As of February 22, 2025, the stock is trading at CAD 2.73 with a total of 30,673 shares traded.
Over the past week, the price has changed by +3.02%, over one month by +26.98%, over three months by +53.37% and over the past year by +77.27%.
Is CareRx a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, CareRx (TO:CRRX) is currently (February 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 40.41 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRRX as of February 2025 is 2.81. This means that CRRX is currently overvalued and has a potential downside of 2.93%.
Partly, yes. Based on ValueRay Fundamental Analyses, CareRx (TO:CRRX) is currently (February 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 40.41 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRRX as of February 2025 is 2.81. This means that CRRX is currently overvalued and has a potential downside of 2.93%.
Is CRRX a buy, sell or hold?
CareRx has no consensus analysts rating.
CareRx has no consensus analysts rating.
What are the forecast for CRRX stock price target?
According to ValueRays Forecast Model, CRRX CareRx will be worth about 3 in February 2026. The stock is currently trading at 2.73. This means that the stock has a potential upside of +10.99%.
According to ValueRays Forecast Model, CRRX CareRx will be worth about 3 in February 2026. The stock is currently trading at 2.73. This means that the stock has a potential upside of +10.99%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 3.5 | 27.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 3 | 11% |